Argen X SE Institutional ownership
What is the Institutional ownership of Argen X SE?
The Institutional ownership of Argen X SE is 63.21%
What is the definition of Institutional ownership?
Institutional Ownership is the amount of a company’s available stock owned by mutual or pension funds, insurance companies, investment firms, endowments or other large entities that manage funds on the behalf of others.
Given the considerable sums of money that institutions invest, it is not surprising that they tend to be much more knowledgeable than the average investor when it comes to the companies and industries in which they have invested.
Institutional portfolio managers often meet personally with a company's top executives, and in many cases the research they conduct is further supported by equity analysts who evaluate prospective companies and industries in great depth before making specific investment recommendations.
Institutional ownership of companies in the Health Care sector on NASDAQ compared to Argen X SE
What does Argen X SE do?
Argenx is a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and cancer.
Companies with institutional ownership similar to Argen X SE
- Kingspan plc has Institutional ownership of 63.11%
- Croda International Plc has Institutional ownership of 63.12%
- Tejon Ranch Co has Institutional ownership of 63.14%
- BeiGene Ltd has Institutional ownership of 63.15%
- DX () Plc has Institutional ownership of 63.20%
- FTAC Olympus Acquisition has Institutional ownership of 63.21%
- Argen X SE has Institutional ownership of 63.21%
- SelectQuote has Institutional ownership of 63.21%
- Tredegar has Institutional ownership of 63.22%
- Impact Healthcare REIT Plc has Institutional ownership of 63.23%
- Cato has Institutional ownership of 63.23%
- Renew plc has Institutional ownership of 63.25%
- Royalty Pharma plc has Institutional ownership of 63.29%